UGISENSE
UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration with partners from the industry and academia. The developments are made on the basis of a proprietary platform technology, i.e. the UgimeresTM. The company, which was first established in 2016, is being financed by private investors and has been accredited by the Federal Office of Economics and Export Control (BAFA) (within the scope of their Funds for Venture Capital program).
UGISENSE
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Dortmund, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.ugisense.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0) 231 97427063
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon WordPress LetsEncrypt SSL By Default Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Paramita Therapeutics
Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
Official Site Inspections
http://www.ugisense.com
- Host name: dd50616.kasserver.com
- IP address: 85.13.149.187
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "UGISense"
ugisense
UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration with partners from the industry and academia. The …See details»
ugisense | Ugisense
UGISense AG was founded in 2016 by Birgit Werner and Thomas Lindhorst, two experienced chemists and entrepreneurs working in biotech for more than 20 years.See details»
UGISense - Crunchbase Company Profile & Funding
UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration with partners from the industry and academia. The …See details»
UGISense Company Profile 2024: Valuation, Funding & Investors
UGISense General Information Description. Developer of therapeutic products in Dortmund, Germany. The company's products include antisense therapeutic agents which are capable of …See details»
UGISense AG - Dortmund, Germany - bionity.com
Jun 21, 2018 UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration with partners from the industry and academia. …See details»
Contact - ugisense
Contact. UGISense AG Otto-Hahn-Straße 15 44227 Dortmund Germany. Tel +49 (0) 231 97427063 or Tel +49 (0) 231 97427062 . Email [email protected]. www.ugisense.comSee details»
UGISense Company Profile - Office Locations, Competitors ... - Craft
UGISense is a biotech company dedicated to developing antisense therapeutic agents in collaboration with partners from the industry and academia. The developments are made on …See details»
UGISense AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for UGISense AG of Dortmund, Nordrhein-Westfalen. Get the latest business insights from Dun & Bradstreet.See details»
UGISense AG - VentureRadar
UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration with partners from the industry and academia. The …See details»
UGISense - Products, Competitors, Financials, Employees, …
UGISense is a company focused on genetic research and biotechnology. It offers gene editing technology and genomic sequencing services to understand and manipulate genetic material. …See details»
UGISense (UGISense AG) - startbase.com
Legal Entity: UGISense AG Location: Nordrhein-Westfalen Overview Company Funding Product Team News Is this your company? Profile is not claimed et. This profile is created by the …See details»
UGISense - Funding, Financials, Valuation & Investors - Crunchbase
UGISense AG is a biotech company dedicated to developing new and innovative antisense therapeutic agents in collaboration. ... Products. Resources. Pricing. Resources. Log In. …See details»
UGISense - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 1, 2024 Organization. UGISense . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 5. Monthly …See details»
Investors - ugisense
© 2024 UGISense AG -All rights reservedSee details»
Thomas Lindhorst - IOPC - International Oligonucleotides and …
Thomas Lindhorst is cofounder and managing director and at UGIsense AG. He holds a PhD in Organic Chemistry from the Technical University of Munich. Thomas is co-developer of the …See details»
UGISense CEO and key executive team | Craft.co
UGISense's Managing Director is Thomas Lindhorst. Other executives include Bert Klebl, Board Member; Nicole Wistuba, Chairman and 2 others. See the full leadership team at Craft.See details»
ugisense | UGISense AG Raises its Series B Round to Advance its ...
UGISense AG is a biotechnology company dedicated to developing a new innovative type of antisense drugs. The developments are made on the basis of a proprietary platform …See details»
Ugimers™ antisense technology UgiSense AG - [LSE] Life-Sciences …
Jun 19, 2018 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Research programme: kidney fibrosis antisense therapeutics
05 Jan 2023 UGISense has patent protection for its UgimersTM technology platform before January 2023 (UGISense pipeline, January 2023) 05 Jan 2023 Early research in Renal fibrosis …See details»
News - ugisense
Meet us at Bio-Europe Spring 2023 | UGISense will attend the Bio-Europe Spring 2023, March 20 – 22, 2023 | Basel, Switzerland. Meet us at Bio€quity 2022 | UGISense will attend Bio€quity …See details»